Ningxia Zhongke Biotechnology Co., Ltd

SHSE:600165 Stock Report

Market Cap: CN¥1.3b

Ningxia Zhongke Biotechnology Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ningxia Zhongke Biotechnology.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth39.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Revenues Not Telling The Story For Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) After Shares Rise 25%

Nov 13
Revenues Not Telling The Story For Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) After Shares Rise 25%

What Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 34% Share Price Gain Is Not Telling You

Aug 30
What Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 34% Share Price Gain Is Not Telling You

Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Looks Just Right With A 50% Price Jump

Jul 12
Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Looks Just Right With A 50% Price Jump

Calculating The Intrinsic Value Of Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165)

Jun 03
Calculating The Intrinsic Value Of Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165)

Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Apr 21
Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

Feb 27
Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ningxia Zhongke Biotechnology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SHSE:600165 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024302-725348N/A
6/30/2024297-754-838N/A
3/31/2024293-459866N/A
12/31/2023286-466-3523N/A
9/30/2023244-340-76-96N/A
6/30/2023308-287-718N/A
3/31/2023561-1774798N/A
12/31/2022681-141-653N/A
9/30/2022712-169-2107N/A
6/30/2022642-146-76-15N/A
3/31/2022377-192-240-109N/A
12/31/2021249-166-258-18N/A
9/30/202119513-4037N/A
6/30/202116116-54213N/A
3/31/202113722-785-28N/A
12/31/202011921-774-41N/A
9/30/202093-24-938-22N/A
6/30/2020199-28-879-44N/A
3/31/2020237-38-550-24N/A
12/31/2019266-45-547-48N/A
9/30/2019311-22-260-95N/A
6/30/2019324-10-222-108N/A
3/31/20194394-327-207N/A
12/31/20185529-254-180N/A
9/30/201858639-522-541N/A
6/30/20181,01946N/A28N/A
3/31/20181,17437N/A101N/A
12/31/20171,24838N/A116N/A
9/30/20171,423-111N/A171N/A
6/30/20171,756-151N/A-184N/A
3/31/20172,382-170N/A-151N/A
12/31/20162,785-192N/A-191N/A
9/30/20162,937-18N/A-295N/A
6/30/20162,28851N/A-407N/A
3/31/20161,55058N/A-420N/A
12/31/20151,07746N/A-235N/A
9/30/2015833-119N/A-107N/A
6/30/2015993-182N/A-144N/A
3/31/20151,152-200N/A-109N/A
12/31/20141,343-108N/A-242N/A
9/30/20141,209-7N/A46N/A
6/30/20141,49018N/A10N/A
3/31/20141,76063N/A49N/A
12/31/20131,7648N/A6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 600165's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 600165's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 600165's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 600165's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 600165's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 600165's Return on Equity is forecast to be high in 3 years time


Discover growth companies